Biohaven Pharmaceutical Holding Company Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BHVN | BMY | AMGN | GILD | ILMN |
| Company | Biohaven Pharmaceutical Holding Company Ltd | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 73.32 | 65.42 | 252.85 | 66.70 | 398.05 |
| High | 74.14 | 65.93 | 256.09 | 67.00 | 405.25 |
| Low | 72.06 | 65.21 | 252.64 | 65.75 | 393.35 |
| Last | 73.07 | 65.67 | 255.64 | 65.75 | 404.89 |
| Change | -1.33 | +0.21 | -0.07 | -1.12 | +5.89 |
| % Change | -1.79% | +0.32% | -0.03% | -1.67% | +1.48% |
| Volume | 306,082 | 7,459,227 | 945,365 | 4,540,361 | 571,641 |
| 20-Day Average Volume | 652,028 | 10,732,642 | 2,132,097 | 6,563,084 | 1,297,058 |
| Previous Close | 74.40 | 65.46 | 255.71 | 66.87 | 399.00 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 69.71 | 63.29 | 250.11 | 65.41 | 399.94 |
| 20-Day Raw Stochastic | 77.41% | 94.46% | 81.77% | 68.21% | 60.11% |
| 20-Day Relative Strength | 49.20% | 64.98% | 64.13% | 54.14% | 49.27% |
| Weighted Alpha | +33.08 | +8.99 | +11.27 | -12.17 | +28.58 |
| Today's Opinion | 56% Sell | 88% Buy | 88% Buy | 88% Buy | 56% Buy |
| Previous Opinion | 56% Sell | 88% Buy | 72% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 40% Sell | 56% Buy | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.10% since 04/12/21 | +4.79% since 04/12/21 | +2.76% since 04/12/21 | +2.01% since 04/12/21 | +1.46% since 04/12/21 |
| Low | 70.08 on 04/13/21 | 62.75 on 04/13/21 | 247.09 on 04/13/21 | 64.15 on 04/13/21 | 390.52 on 04/16/21 |
| High | 76.91 on 04/14/21 | 65.93 on 04/19/21 | 258.82 on 04/16/21 | 67.09 on 04/16/21 | 408.58 on 04/14/21 |
| 1-Month | |||||
| %Chg | +4.54% since 03/19/21 | +4.77% since 03/19/21 | +4.02% since 03/19/21 | +2.33% since 03/19/21 | -2.67% since 03/19/21 |
| Low | 62.57 on 03/30/21 | 61.68 on 04/09/21 | 242.36 on 03/22/21 | 63.53 on 03/25/21 | 364.24 on 03/30/21 |
| High | 76.91 on 04/14/21 | 65.93 on 04/19/21 | 258.82 on 04/16/21 | 67.09 on 04/16/21 | 431.73 on 03/23/21 |
| 3-Month | |||||
| %Chg | -5.34% since 01/19/21 | -1.57% since 01/19/21 | +3.04% since 01/19/21 | -1.65% since 01/19/21 | +3.74% since 01/19/21 |
| Low | 62.57 on 03/30/21 | 58.63 on 03/04/21 | 220.25 on 03/04/21 | 61.39 on 02/26/21 | 364.24 on 03/30/21 |
| High | 93.54 on 01/27/21 | 66.82 on 01/20/21 | 276.69 on 01/28/21 | 69.36 on 02/05/21 | 555.77 on 02/12/21 |
| 6-Month | |||||
| %Chg | -4.93% since 10/19/20 | +8.10% since 10/19/20 | +10.88% since 10/19/20 | +8.90% since 10/19/20 | +26.01% since 10/19/20 |
| Low | 62.57 on 03/30/21 | 56.75 on 10/29/20 | 210.28 on 10/29/20 | 56.56 on 12/31/20 | 288.01 on 10/30/20 |
| High | 100.77 on 11/18/20 | 67.16 on 01/19/21 | 276.69 on 01/28/21 | 69.36 on 02/05/21 | 555.77 on 02/12/21 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,615,851 | 146,232,928 | 147,238,336 | 84,193,080 | 58,214,100 |
| Shares Outstanding, K | 62,041 | 2,233,928 | 575,802 | 1,259,056 | 145,900 |
| Annual Sales | 63,630,000 | 42,518,000,000 | 25,424,000,000 | 24,689,000,000 | 3,239,000,000 |
| Annual Net Income | -766,800,000 | -9,015,000,000 | 7,264,000,000 | 123,000,000 | 656,000,000 |
| Last Quarter Sales | 35,110,000 | 11,068,000,000 | 6,634,000,000 | 7,421,000,000 | 953,000,000 |
| Last Quarter Net Income | -217,740,000 | -10,027,000,000 | 1,615,000,000 | 1,551,000,000 | 257,000,000 |
| 60-Month Beta | 1.01 | 0.64 | 0.74 | 0.39 | 0.98 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.69 on 03/01/21 | 1.46 on 02/04/21 | 3.81 on 02/02/21 | 2.19 on 02/04/21 | 1.22 on 02/11/21 |
| Latest Earnings Date | 05/06/21 | 04/29/21 | 04/27/21 | 04/29/21 | 04/27/21 |
| Most Recent Dividend | N/A | 0.490 on 03/31/21 | 1.760 on 02/11/21 | 0.710 on 03/12/21 | N/A |
| Next Ex-Dividends Date | N/A | 03/31/21 | 05/14/21 | 03/12/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.01 | 15.37 | 9.28 | 89.32 |
